| Shannon Wrona, | |
|
3767 Delaware Ave, Kenmore, NY 14217-1040 | |
| (716) 874-6175 | |
| Not Available |
| Full Name | Shannon Wrona |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 3767 Delaware Ave, Kenmore, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033852116 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 046493 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Wrona, 3767 Delaware Ave, Kenmore, NY 14217-1040 Ph: (716) 874-6175 | Shannon Wrona, 3767 Delaware Ave, Kenmore, NY 14217-1040 Ph: (716) 874-6175 |
News Archive
Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.
These "policy riders" restrict spending on certain social and regulatory initiatives, including implementation of the health law and funding for Planned Parenthood. These contentious issues are becoming as difficult to resolve as reaching agreement on a final figure for spending cuts.
Roche announced today the U.S. introduction of the cobas e 602 analyzer, the latest addition to the cobas 8000 modular analyzer series for diagnostic labs with high-volume workloads. Labs will now be able to combine this new immunoassay module with two existing clinical chemistry modules to create an integrated platform with 24 unique system configurations to match their specific testing needs.
Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE). Abatacept failed to prevent new disease flares in SLE patients tapered from corticosteroids in an analysis where mild, moderate and severe disease flares were evaluated together. Full details of the phase IIb clinical trial are published in the October issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).
› Verified 7 days ago
Sharon Karnyski, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 Delaware Avenu, Kenmore, NY 14217 Phone: 716-871-9883 Fax: 716-871-9887 | |
Megan Overlan, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3767 Delaware Ave, Kenmore, NY 14217 Phone: 716-874-6175 | |
Amanda Schoenthal-martin, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3767 Delaware Ave, Kenmore, NY 14217 Phone: 716-874-6175 | |
Marissa Dalio, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3767 Delaware Ave, Kenmore, NY 14217 Phone: 716-874-6175 | |
Sarah Kociszewski, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 Delaware Ave, Kenmore, NY 14217 Phone: 716-871-9883 | |
Christine Woodrick, PT DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2760 Delaware Ave, Kenmore, NY 14217 Phone: 716-423-2262 Fax: 716-423-2263 |